1. Home
  2. CALX vs NVCR Comparison

CALX vs NVCR Comparison

Compare CALX & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calix Inc

CALX

Calix Inc

HOLD

Current Price

$35.49

Market Cap

2.5B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$16.64

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALX
NVCR
Founded
1999
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
CALX
NVCR
Price
$35.49
$16.64
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$66.50
$28.08
AVG Volume (30 Days)
721.9K
1.0M
Earning Date
04-21-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
157.78
21.79
EPS
0.42
N/A
Revenue
$510,367,000.00
$655,353,000.00
Revenue This Year
$16.40
$7.72
Revenue Next Year
$13.75
$6.74
P/E Ratio
$84.14
N/A
Revenue Growth
11.24
8.28
52 Week Low
$34.26
$9.82
52 Week High
$71.22
$21.45

Technical Indicators

Market Signals
Indicator
CALX
NVCR
Relative Strength Index (RSI) 33.63 45.50
Support Level $34.72 $16.33
Resistance Level $41.02 $18.41
Average True Range (ATR) 1.08 0.80
MACD -0.41 -0.08
Stochastic Oscillator 10.21 15.13

Price Performance

Historical Comparison
CALX
NVCR

About CALX Calix Inc

Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Europe, Americas excluding U.S., and Rest of World.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: